CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 11.71: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
728.48MUSDvs all stocks (USD)
Revenue (TTM)
48.47MUSDvs all stocks (USD)
Profit Margin
-20.69%vs Medical Devices peers
Beta
0.5600xvs all stocks
52-Week Change
-56.67%vs all stocks
Market Capitalization
728.48MUSDvs all stocks (USD)
Enterprise Value
726.32MUSDvs all stocks (USD)
Forward P/E
-60.67xvs Medical Devices peers
Price to Sales (TTM)
15.03xvs Medical Devices peers
Price to Book (MRQ)
13.38xvs Medical Devices peers
Enterprise to Revenue
14.99xvs Medical Devices peers
Enterprise to EBITDA
-153.88xvs Medical Devices peers
Gross Margin
47.99%vs Medical Devices peers
Profit Margin
-20.69%vs Medical Devices peers
Operating Margin
-32.78%vs Medical Devices peers
Return on Assets (TTM)
-4.80%vs Medical Devices peers
Return on Equity (TTM)
-21.10%vs Medical Devices peers
Revenue (TTM)
48.47MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.2490USDUpdated Jul 19, 2026Quarterly Revenue Growth
116.80%vs Medical Devices peers
Gross Profit (TTM)
23.78MUSDvs all stocks (USD)
EBITDA (TTM)
-4.72MUSDvs all stocks (USD)
Net Income (TTM)
-10.03MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
116.80%vs Medical Devices peers
Operating Cash Flow (TTM)
-14.75MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-124.14KUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
42.48MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
22.94MUSDFY2025 · Dec 31, 2025Gross Profit
19.54MUSDFY2025 · Dec 31, 2025Operating Income
-8.19MUSDvs all stocks (USD)
Pre-tax Income
-8.16MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.97MUSDFY2025 · Dec 31, 2025Net Income
-12.13MUSDFY2025 · Dec 31, 2025EBIT
-7.05MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-5.98MUSDFY2025 · Dec 31, 2025Research & Development
3.69MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
22.98MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
1.14MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.11MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0600USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
190.01MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
190.01MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-12.13MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-18.03MUSDFY2025 · Dec 31, 2025Free Cash Flow
-21.69MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
9.60MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-12.13MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.08MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-512.87KUSDFY2025 · Dec 31, 2025Stock-based Compensation
8.13MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-318.89KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-13.04MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.88MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.12MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.66MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.66MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
28.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-5.28MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
3.45MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
26.17MUSDFY2025 · Dec 31, 2025Shares Outstanding
200.13MSharesUpdated Jul 19, 2026Float Shares
40.32MSharesUpdated Jul 19, 2026Shares Short
46.92KSharesUpdated Jul 19, 2026Short Ratio
0.6600daysvs all stocks
Short % of Shares Outstanding
0.09%vs all stocks
% Held by Insiders
80.21%vs all stocks
% Held by Institutions
0.88%vs all stocks
Total Cash (MRQ)
15.98MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.0800USDUpdated Jul 19, 2026Total Debt (MRQ)
13.82MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2535xvs Medical Devices peers
Current Ratio (MRQ)
2.54xvs Medical Devices peers
Book Value per Share (MRQ)
0.2720USDUpdated Jul 19, 2026Total Assets
74.23MUSDvs all stocks (USD)
Total Current Assets
48.80MUSDFY2025 · Dec 31, 2025Total Liabilities
36.01MUSDFY2025 · Dec 31, 2025Total Non-current Assets
25.43MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
9.77MUSDFY2025 · Dec 31, 2025Total Current Liabilities
26.24MUSDFY2025 · Dec 31, 2025Cash
3.21MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.21MUSDFY2025 · Dec 31, 2025Accounts Receivable
12.40MUSDFY2025 · Dec 31, 2025Inventory
17.06MUSDFY2025 · Dec 31, 2025Accounts Payable
5.13MUSDFY2025 · Dec 31, 2025Short-term Debt
12.02MUSDFY2025 · Dec 31, 2025Deferred Revenue
3.27MUSDFY2025 · Dec 31, 2025Long-term Debt
2.34MUSDFY2025 · Dec 31, 2025Common Stock (Book)
19.42KUSDFY2025 · Dec 31, 2025Retained Earnings
-55.79MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
38.22MUSDvs all stocks (USD)
52-Week Low
3.11USDUpdated Jul 19, 202652-Week High
10.00USDUpdated Jul 19, 202652-Week Change
-56.67%vs all stocks
Beta
0.5600xvs all stocks
50-Day MA
3.75USDUpdated Jul 19, 2026200-Day MA
5.18USDUpdated Jul 19, 2026Avg 10-Day Volume
58.37KSharesUpdated Jul 19, 2026Avg 30-Day Volume
63.42KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-0.0500USDUpdated Jul 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: -0.21
Financial Health
Altman Z-Score 11.71: safe zoneNotable
Altman Z-Score: 11.71
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Getein Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRule
Immix Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guangdong Biolight Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Yabao Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sanyou Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Teyi Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow